FUSION PROTEIN COMPOSITION(S) COMPRISING TARGETED MASKED TYPE I INTERFERONS (IFNA AND IFNB) AND AN ANTIBODY AGAINST TUMOR ANTIGEN, FOR USE IN THE TREATMENT OF CANCER

摘要

Fusion Protein compositions comprising masked IFNs and methods of making masked IFNs are disclosed herein. Consequently, the masked IFNs can be fused to a Mab or binding fragment thereof and be administered to patients as a therapeutic modality and provide a method of treating cancer, immunological disorders and other disease.